There are several key considerations when broaching the subject with patients, speakers said at JADPRO Live 2023. Mary B. Morgan, MSN, ANP-BC, AOCN, discusses the real-world uses of circulating tumor DNA in colorectal cancer. Speakers from a JADPRO Live session on CRC explain how to tailor therapy for patients. A session at JAPDRO Live 2023, the Annual APSHO Meeting, outlined what providers must know about treating this population. There are several ways to overcome barriers surrounding screening for CRC, speakers said at a JADPRO Live session on CRC. Researchers assessed if APP-led education could improve the use of tumor markers for CRC and other cancers. At treatment discontinuation, 91% of patients in the FTD/TPI cohort remained at an ECOG performance status of 0 or 1. Authors of the FRESCO-2 clinical trial reported on treatment-emergent AEs of special interest. A sexual survivorship program is a “feasible” way to manage the sexual effects of pelvic radiotherapy for rectal cancer.